SAM

Simplify Asset Management Portfolio holdings

AUM $4.93B
1-Year Est. Return 7.16%
This Quarter Est. Return
1 Year Est. Return
+7.16%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.65B
AUM Growth
-$492M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
110
New
Increased
Reduced
Closed

Top Buys

1 +$28.8M
2 +$26.6M
3 +$6.47M
4
AGG icon
iShares Core US Aggregate Bond ETF
AGG
+$6.2M
5
WGS icon
GeneDx Holdings
WGS
+$5.23M

Sector Composition

1 Healthcare 7.81%
2 Energy 1.5%
3 Consumer Discretionary 0.88%
4 Industrials 0.66%
5 Consumer Staples 0.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GH icon
51
Guardant Health
GH
$13.7B
$1.39M 0.07%
+26,631
BHVN icon
52
Biohaven
BHVN
$1.24B
$1.36M 0.07%
+96,389
NKTR icon
53
Nektar Therapeutics
NKTR
$1.24B
$1.34M 0.07%
+51,998
ABT icon
54
Abbott
ABT
$223B
$1.33M 0.07%
9,794
-1,064
ZVRA icon
55
Zevra Therapeutics
ZVRA
$470M
$1.3M 0.07%
147,000
+27,000
UNH icon
56
UnitedHealth
UNH
$293B
$1.26M 0.06%
4,051
-9,376
IQV icon
57
IQVIA
IQV
$38.9B
$1.25M 0.06%
+7,940
NLY icon
58
Annaly Capital Management
NLY
$15.6B
$1.18M 0.06%
62,900
-42,290
SNY icon
59
Sanofi
SNY
$121B
$1M 0.05%
20,716
-19,881
TMO icon
60
Thermo Fisher Scientific
TMO
$220B
$871K 0.04%
2,147
-6,923
BNTC icon
61
Benitec Biopharma
BNTC
$414M
$809K 0.04%
69,173
-7,562
ARGX icon
62
argenx
ARGX
$55.1B
$809K 0.04%
1,467
-152
AGNC icon
63
AGNC Investment
AGNC
$11.2B
$790K 0.04%
86,000
-235,550
BSX icon
64
Boston Scientific
BSX
$150B
$763K 0.04%
+7,103
EYPT icon
65
EyePoint Pharmaceuticals
EYPT
$1.18B
$748K 0.04%
79,472
-8,683
CIM
66
Chimera Investment
CIM
$1.07B
$708K 0.04%
51,025
-19,675
EW icon
67
Edwards Lifesciences
EW
$49.5B
$691K 0.03%
8,830
-969
NXTI icon
68
Simplify Next Intangible Core Index ETF
NXTI
$34.7M
$686K 0.03%
22,303
-3,522
LGND icon
69
Ligand Pharmaceuticals
LGND
$3.88B
$679K 0.03%
5,970
-646
TWO
70
Two Harbors Investment
TWO
$1.06B
$574K 0.03%
53,250
+22,250
RARE icon
71
Ultragenyx Pharmaceutical
RARE
$3.22B
$553K 0.03%
15,210
-1,690
CI icon
72
Cigna
CI
$73.1B
$510K 0.03%
1,544
-19,815
FULC icon
73
Fulcrum Therapeutics
FULC
$534M
$503K 0.03%
73,154
-7,980
VRTX icon
74
Vertex Pharmaceuticals
VRTX
$108B
$481K 0.02%
1,081
-114
ATHA icon
75
Athira Pharma
ATHA
$16.8M
$451K 0.02%
149,279